Page last updated: 2024-09-04

lonafarnib and Kidney Neoplasms

lonafarnib has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Boumber, Y; Fazliyeva, R; Khazak, V; Kolenko, VM; Makhov, P; Serebriiskii, IG; Sohn, JA; Uzzo, RG	1

Other Studies

1 other study(ies) available for lonafarnib and Kidney Neoplasms

Article	Year
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma. British journal of cancer, 2020, Volume: 123, Issue:12 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; CRISPR-Cas Systems; DNA Fragmentation; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Enzyme Inhibitors; Farnesyltranstransferase; High-Throughput Screening Assays; Humans; Kidney Neoplasms; Lysosomes; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Molecular Targeted Therapy; Neoplasm Transplantation; Piperidines; Progression-Free Survival; Protein Kinase Inhibitors; Pyridines; Random Allocation; RNA, Small Interfering; Sunitinib	2020

Article

Year

CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma.

British journal of cancer, 2020, Volume: 123, Issue:12

Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; CRISPR-Cas Systems; DNA Fragmentation; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Enzyme Inhibitors; Farnesyltranstransferase; High-Throughput Screening Assays; Humans; Kidney Neoplasms; Lysosomes; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Molecular Targeted Therapy; Neoplasm Transplantation; Piperidines; Progression-Free Survival; Protein Kinase Inhibitors; Pyridines; Random Allocation; RNA, Small Interfering; Sunitinib

2020